Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
No open-market purchases or sales by Oramed Pharmaceuticals Inc. insiders were filed in the last 90 days; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Oramed Pharmaceuticals Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 77 | 2 | 61 | −14 |
| Shares | 3.60M | 9.65K | 4.26M | +669.4K (+18.6%) |
| Value | $43.2M | $116.5K | $9.29M | −$33.8M (−78.4%) |
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BML Capital Management, LLC | 1,355,925 | $2.96M | 2.56% |
| Two Sigma Investments, LP | 506,255 | $1.10M | 0.00% |
| Susquehanna International Group Ltd. | 113,526 | $247.5K | 0.14% |
| ETF Managers Group, LLC | 68,940 | $150.3K | 0.00% |
| Corsair Capital Management, L.P. | 47,256 | $103.0K | 0.04% |
| HRT Financial LP | 45,035 | $98.0K | 0.00% |
| Walleye Capital LLC | 36,102 | $78.7K | 0.00% |
| Verition Fund Management LLC | 20,550 | $44.8K | 0.00% |
| Apollon Wealth Management, LLC | 20,000 | $43.6K | 0.00% |
| Schonfeld Strategic Advisors LLC | 17,400 | $37.9K | 0.00% |
| Diametric Capital, LP | 14,314 | $31.2K | 0.02% |
| Invesco Ltd. | 13,375 | $29.2K | 0.00% |
| Two Sigma Securities, LLC | 12,962 | $28.3K | 0.00% |
| Renaissance Technologies LLC | 11,900 | $26.0K | 0.00% |
| Federated Hermes, Inc. | 684 | $1.49K | 0.00% |
Sold out (29)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (2)
Institutions that held Oramed Pharmaceuticals Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Glass Jacobson Investment Advisors llc | 9,350 | $112.5K |
| Tyler-Stone Wealth Management | 300 | $4.00K |